Cysteamine in treatment of type III hyperlipidaemia?
D000818:Animals; D003543:Cysteamine / Q000009:adverse effects / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000188:drug therapy*; D008079:Lipoproteins, VLDL / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D018110:Receptors, Lipoprotein
D008079:Lipoproteins, VLDL; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; D003543:Cysteamine